Hier geht's zu dieser Studie:
vaccelerate.eu/mak-5-50/
vaccelerate.eu/mak-5-50/
MAK 5 50+ – VACCELERATE
vaccelerate.eu
June 24, 2024 at 6:02 PM
Hier geht's zu dieser Studie:
vaccelerate.eu/mak-5-50/
vaccelerate.eu/mak-5-50/
EU-funded #VACCELERATE has successfully concluded with a positive expert review: www.uni-koeln.de/en/universit... Proud of our Europe-wide network, volunteer registry & training that will strengthen future vaccine research and pandemic preparedness. Onwards! 🚀#pandemicpreparedness #EUresearch
EU-funded VACCELERATE Project concludes with positive assessment
An independent expert review commissioned by the Health and Digital Executive Agency (HaDEA) confirms that the four-year project coordinated in Cologne has made a successful contribution to preparing ...
www.uni-koeln.de
December 19, 2025 at 7:58 AM
EU-funded #VACCELERATE has successfully concluded with a positive expert review: www.uni-koeln.de/en/universit... Proud of our Europe-wide network, volunteer registry & training that will strengthen future vaccine research and pandemic preparedness. Onwards! 🚀#pandemicpreparedness #EUresearch
Proud to have represented at ESCMID Global 2025 with 15 posters, 8 talks & 14 dedicated team members!
A big thank you to everyone who shared insights, connected, and contributed to advancing infectious disease research.
#ESCMIDGlobal #InfectiousDiseases #VACCELERATE
A big thank you to everyone who shared insights, connected, and contributed to advancing infectious disease research.
#ESCMIDGlobal #InfectiousDiseases #VACCELERATE
April 16, 2025 at 8:06 AM
Proud to have represented at ESCMID Global 2025 with 15 posters, 8 talks & 14 dedicated team members!
A big thank you to everyone who shared insights, connected, and contributed to advancing infectious disease research.
#ESCMIDGlobal #InfectiousDiseases #VACCELERATE
A big thank you to everyone who shared insights, connected, and contributed to advancing infectious disease research.
#ESCMIDGlobal #InfectiousDiseases #VACCELERATE
Die #SARSCoV2-Prävalenz am Stichtag 1.6. lag bei den 2.648 Testungen (GesamtteilnehmerInnen n = 3.162) bei 1,13 %.‼️👀
Hier der Link:
vaccelerate.eu/mak-5-50/
#COVID19 #Coronavirus #LongCovid #CovidIsNotOver #Pandemie #CleanAir #MaskUp #ImpfenSchuetzt #MECFS #VaccinesSaveLives
Hier der Link:
vaccelerate.eu/mak-5-50/
#COVID19 #Coronavirus #LongCovid #CovidIsNotOver #Pandemie #CleanAir #MaskUp #ImpfenSchuetzt #MECFS #VaccinesSaveLives
MAK 5 50+ – VACCELERATE
vaccelerate.eu
June 24, 2024 at 10:38 PM
Die #SARSCoV2-Prävalenz am Stichtag 1.6. lag bei den 2.648 Testungen (GesamtteilnehmerInnen n = 3.162) bei 1,13 %.‼️👀
Hier der Link:
vaccelerate.eu/mak-5-50/
#COVID19 #Coronavirus #LongCovid #CovidIsNotOver #Pandemie #CleanAir #MaskUp #ImpfenSchuetzt #MECFS #VaccinesSaveLives
Hier der Link:
vaccelerate.eu/mak-5-50/
#COVID19 #Coronavirus #LongCovid #CovidIsNotOver #Pandemie #CleanAir #MaskUp #ImpfenSchuetzt #MECFS #VaccinesSaveLives
Today, the #VACCELERATE Showcase Event highlighted four years of achievements in EU #vaccine #research! Missed it? Watch the recording and discover how we accelerated #clinicaltrials and built a strong network for the future: www.youtube.com/watch?v=wf_H... #VACCELERATE #VaccineResearch
VACCELERATE SHOWCASE EVENT JANUARY 23 2025: Project Highlights, Key Results & Research Impact
YouTube video by VACCELERATE_EU
www.youtube.com
January 23, 2025 at 12:17 PM
Today, the #VACCELERATE Showcase Event highlighted four years of achievements in EU #vaccine #research! Missed it? Watch the recording and discover how we accelerated #clinicaltrials and built a strong network for the future: www.youtube.com/watch?v=wf_H... #VACCELERATE #VaccineResearch
📢 Don’t miss our upcoming VACCELERATE webinar: How can data standards boost COVID-19 vaccine trial efficiency?
🗓️ May 13 | 10:00–11:00 CEST
✅ Now EACCME®-accredited (1 CME credit)!
📌 Register: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #CME #COVID19 #ClinicalTrials
🗓️ May 13 | 10:00–11:00 CEST
✅ Now EACCME®-accredited (1 CME credit)!
📌 Register: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #CME #COVID19 #ClinicalTrials
April 29, 2025 at 9:19 AM
📢 Don’t miss our upcoming VACCELERATE webinar: How can data standards boost COVID-19 vaccine trial efficiency?
🗓️ May 13 | 10:00–11:00 CEST
✅ Now EACCME®-accredited (1 CME credit)!
📌 Register: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #CME #COVID19 #ClinicalTrials
🗓️ May 13 | 10:00–11:00 CEST
✅ Now EACCME®-accredited (1 CME credit)!
📌 Register: uni-koeln.zoom.us/meeting/regi...
#VACCELERATE #CME #COVID19 #ClinicalTrials
📅 5 years ago, the WHO declared COVID-19 a pandemic. This anniversary reminds us: Research & preparedness matter! 💉 #VACCELERATE continues to advance clinical trials for faster vaccine development through its Volunteer Registry & Site Network. Join us in shaping the future: vaccelerate.eu #COVID19
VACCELERATE
vaccelerate.eu
March 11, 2025 at 9:47 AM
📅 5 years ago, the WHO declared COVID-19 a pandemic. This anniversary reminds us: Research & preparedness matter! 💉 #VACCELERATE continues to advance clinical trials for faster vaccine development through its Volunteer Registry & Site Network. Join us in shaping the future: vaccelerate.eu #COVID19
📢 The final VACCELERATE webinar is now online! 🎥 Dive into insights on data interoperability in COVID-19 vaccine trials. Don’t miss this session with top experts.
Watch now 👉 www.youtube.com/watch?v=blFe... #VACCELERATE #ClinicalResearch #COVID19 @ecrin.bsky.social
Watch now 👉 www.youtube.com/watch?v=blFe... #VACCELERATE #ClinicalResearch #COVID19 @ecrin.bsky.social
VACCELERATE WEBINAR May 13 2025: Data Interoperability in COVID-19 Vaccine Trials
YouTube video by VACCELERATE_EU
www.youtube.com
May 15, 2025 at 6:49 AM
📢 The final VACCELERATE webinar is now online! 🎥 Dive into insights on data interoperability in COVID-19 vaccine trials. Don’t miss this session with top experts.
Watch now 👉 www.youtube.com/watch?v=blFe... #VACCELERATE #ClinicalResearch #COVID19 @ecrin.bsky.social
Watch now 👉 www.youtube.com/watch?v=blFe... #VACCELERATE #ClinicalResearch #COVID19 @ecrin.bsky.social
Das ist nicht mehr korrekt, alle 20 Jahre darf man es bei der Tetanusauffrischung gerne dazu nehmen! Gab mal eine Studie von Vaccelerate, wo man das abschätzen lassen konnte
November 29, 2024 at 6:07 AM
Das ist nicht mehr korrekt, alle 20 Jahre darf man es bei der Tetanusauffrischung gerne dazu nehmen! Gab mal eine Studie von Vaccelerate, wo man das abschätzen lassen konnte
Wir freuen uns über den Beitrag von KölnTourismus zu unserem Freiwilligenregister v-reg! 🙌
Jetzt informieren:
location.koelntourismus.de/veranstaltun...
Mitmachen: v-reg.eu
#KlinischeForschung #Studienteilnahme
Jetzt informieren:
location.koelntourismus.de/veranstaltun...
Mitmachen: v-reg.eu
#KlinischeForschung #Studienteilnahme
Forschungsprojekt VACCELERATE des CECAD abgeschlossen | locations.koeln
Ziel des Projekts war es, eine europaweite Forschungsinfrastruktur für klinische Impfstoffstudien aufzubauen. Hier mehr erfahren.
location.koelntourismus.de
July 3, 2026 at 9:04 AM
Wir freuen uns über den Beitrag von KölnTourismus zu unserem Freiwilligenregister v-reg! 🙌
Jetzt informieren:
location.koelntourismus.de/veranstaltun...
Mitmachen: v-reg.eu
#KlinischeForschung #Studienteilnahme
Jetzt informieren:
location.koelntourismus.de/veranstaltun...
Mitmachen: v-reg.eu
#KlinischeForschung #Studienteilnahme
Exciting discussions, inspiring talks, and valuable insights! Today marked the #VACCELERATE Annual Meeting, celebrating milestones in clinical trial networks and #volunteer engagement. Thank you to all contributors for driving innovation in (#vaccine) #research! #ClinicalTrials
January 21, 2025 at 12:10 PM
Exciting discussions, inspiring talks, and valuable insights! Today marked the #VACCELERATE Annual Meeting, celebrating milestones in clinical trial networks and #volunteer engagement. Thank you to all contributors for driving innovation in (#vaccine) #research! #ClinicalTrials
Join the #VACCELERATE #SiteNetwork! 🚀 A Europe-wide platform connecting clinical trial sites & volunteers to accelerate research. Let's work together for a healthier future! 🏥🔬
More information: vaccelerate.eu/site-network/
#ClinicalTrials #Research
More information: vaccelerate.eu/site-network/
#ClinicalTrials #Research
March 5, 2025 at 11:06 AM
Join the #VACCELERATE #SiteNetwork! 🚀 A Europe-wide platform connecting clinical trial sites & volunteers to accelerate research. Let's work together for a healthier future! 🏥🔬
More information: vaccelerate.eu/site-network/
#ClinicalTrials #Research
More information: vaccelerate.eu/site-network/
#ClinicalTrials #Research
PRÓXIMA PANDEMIA MUNDIAL PODE VIR DE VÍRUS CONHECIDO NO BRASIL.
A próxima pandemia q o mundo poderá enfrentar virá de uma variação ou mutação do vírus influenza. Cientistas do consórcio Vaccelerate fazem o alerta ao coletar informações de profissionais de saúde e infectologistas de todo o mundo.
A próxima pandemia q o mundo poderá enfrentar virá de uma variação ou mutação do vírus influenza. Cientistas do consórcio Vaccelerate fazem o alerta ao coletar informações de profissionais de saúde e infectologistas de todo o mundo.
April 24, 2024 at 1:24 AM
PRÓXIMA PANDEMIA MUNDIAL PODE VIR DE VÍRUS CONHECIDO NO BRASIL.
A próxima pandemia q o mundo poderá enfrentar virá de uma variação ou mutação do vírus influenza. Cientistas do consórcio Vaccelerate fazem o alerta ao coletar informações de profissionais de saúde e infectologistas de todo o mundo.
A próxima pandemia q o mundo poderá enfrentar virá de uma variação ou mutação do vírus influenza. Cientistas do consórcio Vaccelerate fazem o alerta ao coletar informações de profissionais de saúde e infectologistas de todo o mundo.
Exciting results from our VACCELERATE pilot study! 🌟 Volunteers self-tested for 5 respiratory viruses, giving real-time insights into infections in the community. A great step for citizen science & public health!
🔗 www.frontiersin.org/journals/pub...
🔗 www.frontiersin.org/journals/pub...
Frontiers | Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infe...
BackgroundAcute respiratory infections (ARI) are the most common human infections. Diagnostic testing for respiratory pathogens is largely restricted to medi...
www.frontiersin.org
September 3, 2025 at 8:56 AM
Exciting results from our VACCELERATE pilot study! 🌟 Volunteers self-tested for 5 respiratory viruses, giving real-time insights into infections in the community. A great step for citizen science & public health!
🔗 www.frontiersin.org/journals/pub...
🔗 www.frontiersin.org/journals/pub...
Today marks the final day of #EUfunding for #VACCELERATE. A heartfelt thank you to everyone who advanced (#vaccine) #research across #EU. The great infrastructure we built will remain for future collaboration #VolunteerRegistry #SiteNetwork #StudyNurseCourse. Together, we make a difference!
January 27, 2025 at 8:02 AM
Today marks the final day of #EUfunding for #VACCELERATE. A heartfelt thank you to everyone who advanced (#vaccine) #research across #EU. The great infrastructure we built will remain for future collaboration #VolunteerRegistry #SiteNetwork #StudyNurseCourse. Together, we make a difference!
🎥 Watch the recording of the #VACCELERATE webinar on Long COVID clinical trials with @scheibenbogen.bsky.social from 2023! 🧬 Gain insights into research challenges and ongoing studies. 📚
📺 Watch here: www.youtube.com/watch?v=fATa...
#LongCOVID #ClinicalTrials #Research
📺 Watch here: www.youtube.com/watch?v=fATa...
#LongCOVID #ClinicalTrials #Research
February 17, 2025 at 9:12 AM
🎥 Watch the recording of the #VACCELERATE webinar on Long COVID clinical trials with @scheibenbogen.bsky.social from 2023! 🧬 Gain insights into research challenges and ongoing studies. 📚
📺 Watch here: www.youtube.com/watch?v=fATa...
#LongCOVID #ClinicalTrials #Research
📺 Watch here: www.youtube.com/watch?v=fATa...
#LongCOVID #ClinicalTrials #Research
Latest results from the MAK5-50+ study: #FluA cases are at 2, while #COVID19 cases stand at 1. A closer look at the trends of the #FluSeason. Stay informed and follow updates at vaccelerate.eu/mak-5-50/.
#FluA #MAK550 #Influenza #RSV #VACCELERATE #PublicHealth
#FluA #MAK550 #Influenza #RSV #VACCELERATE #PublicHealth
February 26, 2025 at 11:37 AM
Latest results from the MAK5-50+ study: #FluA cases are at 2, while #COVID19 cases stand at 1. A closer look at the trends of the #FluSeason. Stay informed and follow updates at vaccelerate.eu/mak-5-50/.
#FluA #MAK550 #Influenza #RSV #VACCELERATE #PublicHealth
#FluA #MAK550 #Influenza #RSV #VACCELERATE #PublicHealth
📢 Latest MAK5-50+ Study Update! 🦠📊
In week 11, we detected 1 Flu A 🏥 and 1 ADV 🧬 case. Stay informed about respiratory virus trends!
📍 More details here: vaccelerate.eu/mak-5-50/
#MAK550+ #FluA #Adenovirus #PublicHealth #VACCELERATE
In week 11, we detected 1 Flu A 🏥 and 1 ADV 🧬 case. Stay informed about respiratory virus trends!
📍 More details here: vaccelerate.eu/mak-5-50/
#MAK550+ #FluA #Adenovirus #PublicHealth #VACCELERATE
March 19, 2025 at 11:54 AM
📢 Latest MAK5-50+ Study Update! 🦠📊
In week 11, we detected 1 Flu A 🏥 and 1 ADV 🧬 case. Stay informed about respiratory virus trends!
📍 More details here: vaccelerate.eu/mak-5-50/
#MAK550+ #FluA #Adenovirus #PublicHealth #VACCELERATE
In week 11, we detected 1 Flu A 🏥 and 1 ADV 🧬 case. Stay informed about respiratory virus trends!
📍 More details here: vaccelerate.eu/mak-5-50/
#MAK550+ #FluA #Adenovirus #PublicHealth #VACCELERATE
Last week’s data shows a continued decline in #SARSCoV2 cases, with only a few positives for other #respiratory #viruses. Two #Influenza cases were detected—we’re curious to see if numbers rise soon. Stay vigilant! Updates: vaccelerate.eu/mak-5-50/ #PublicHealth #VACCELERATE #ClinicalResearch
January 29, 2025 at 4:40 PM
Last week’s data shows a continued decline in #SARSCoV2 cases, with only a few positives for other #respiratory #viruses. Two #Influenza cases were detected—we’re curious to see if numbers rise soon. Stay vigilant! Updates: vaccelerate.eu/mak-5-50/ #PublicHealth #VACCELERATE #ClinicalResearch
vaccelerate.eu/mak-5-50/
Inzidenz 379 für SARS-CoV-2 Infektionen in KW24/2024 innerhalb der MAK 50+ Studie
Inzidenz 379 für SARS-CoV-2 Infektionen in KW24/2024 innerhalb der MAK 50+ Studie
June 24, 2024 at 5:37 PM
vaccelerate.eu/mak-5-50/
Inzidenz 379 für SARS-CoV-2 Infektionen in KW24/2024 innerhalb der MAK 50+ Studie
Inzidenz 379 für SARS-CoV-2 Infektionen in KW24/2024 innerhalb der MAK 50+ Studie
Boosting #DataInteroperability in #COVID19 vaccine trials! 🏥📊 The #VACCELERATE project shows how standardized clinical trial data improve efficiency, analysis & secure exchange. A unified approach = better research! 🔬💡 Read more: www.sciencedirect.com/org/science/... #ClinicalTrials #HealthTech
Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project
Data standards are not only key to making data processing efficient but also fundamental to ensuring data interoperability. When clinical trial data a…
www.sciencedirect.com
March 10, 2025 at 1:13 PM
Boosting #DataInteroperability in #COVID19 vaccine trials! 🏥📊 The #VACCELERATE project shows how standardized clinical trial data improve efficiency, analysis & secure exchange. A unified approach = better research! 🔬💡 Read more: www.sciencedirect.com/org/science/... #ClinicalTrials #HealthTech
Enhance your skills with the VACCELERATE #StudyNurse Course! 🚀 Gain essential knowledge for #clinicalresearch and boost your career in a flexible, interactive format. Sign up now and be part of the future of #clinicaltrials! vaccelerate.eu/study-nurse-...
January 29, 2025 at 10:50 AM
Enhance your skills with the VACCELERATE #StudyNurse Course! 🚀 Gain essential knowledge for #clinicalresearch and boost your career in a flexible, interactive format. Sign up now and be part of the future of #clinicaltrials! vaccelerate.eu/study-nurse-...
📊 Poll result from our recent VACCELERATE webinar on data interoperability in COVID-19 vaccine trials:
50% of participants say ethics & consent structure is the most critical aspect for successful data sharing, followed by data collection procedures (30%). #VACCELERATE #ClinicalResearch
50% of participants say ethics & consent structure is the most critical aspect for successful data sharing, followed by data collection procedures (30%). #VACCELERATE #ClinicalResearch
May 16, 2025 at 10:17 AM
📊 Poll result from our recent VACCELERATE webinar on data interoperability in COVID-19 vaccine trials:
50% of participants say ethics & consent structure is the most critical aspect for successful data sharing, followed by data collection procedures (30%). #VACCELERATE #ClinicalResearch
50% of participants say ethics & consent structure is the most critical aspect for successful data sharing, followed by data collection procedures (30%). #VACCELERATE #ClinicalResearch
Join us on coming Thursday, 23 January 2025, 10:00-11:00 CET for the #VACCELERATE Showcase Event! 🌍✨ Celebrate the achievements of Europe’s vaccine research network.
Free registration: uni-koeln.zoom.us/meeting/regi...
Free registration: uni-koeln.zoom.us/meeting/regi...
January 20, 2025 at 10:04 AM
Join us on coming Thursday, 23 January 2025, 10:00-11:00 CET for the #VACCELERATE Showcase Event! 🌍✨ Celebrate the achievements of Europe’s vaccine research network.
Free registration: uni-koeln.zoom.us/meeting/regi...
Free registration: uni-koeln.zoom.us/meeting/regi...
Last week's #MAK5-50+ results:
🦠 #Influenza A: 7
🦠 Influenza B: 4
🦠 #COVID19: 3
🦠 #RSV: 2
#Flu A leads, but multiple #viruses detected. Stay vigilant & take precautions.
Updates: vaccelerate.eu/mak-5-50/
#PublicHealth #VACCELERATE #ClinicalResearch #VirusTracking
🦠 #Influenza A: 7
🦠 Influenza B: 4
🦠 #COVID19: 3
🦠 #RSV: 2
#Flu A leads, but multiple #viruses detected. Stay vigilant & take precautions.
Updates: vaccelerate.eu/mak-5-50/
#PublicHealth #VACCELERATE #ClinicalResearch #VirusTracking
February 6, 2025 at 10:40 AM
Last week's #MAK5-50+ results:
🦠 #Influenza A: 7
🦠 Influenza B: 4
🦠 #COVID19: 3
🦠 #RSV: 2
#Flu A leads, but multiple #viruses detected. Stay vigilant & take precautions.
Updates: vaccelerate.eu/mak-5-50/
#PublicHealth #VACCELERATE #ClinicalResearch #VirusTracking
🦠 #Influenza A: 7
🦠 Influenza B: 4
🦠 #COVID19: 3
🦠 #RSV: 2
#Flu A leads, but multiple #viruses detected. Stay vigilant & take precautions.
Updates: vaccelerate.eu/mak-5-50/
#PublicHealth #VACCELERATE #ClinicalResearch #VirusTracking